Ullet index:Sumitomo Pharma Co., Ltd.:4506

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Sumitomo Pharma Co., Ltd. Go to web site 4506 Medicals 東証プライム March 1, 2000 1949.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp

Sumitomo Pharma Co., Ltd. mark.gifUllet indexHelp  (Unit:Millions of Yen)

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Shareholder's EquityHelp - - - - -
Shareholder's EquityHelp (*include Wire-Down) 156,063
plusdown
406,749
plusdown
607,888
plusup
580,570
plusup
532,670
plus
Increase and decrease in current net earnings(*include Wire-Down) - - - - -
Net IncomeHelp -314,969
plusdown
-74,512
plusdown
56,413
plusup
56,219
plusup
40,753
plus
Operating Cash Flow(OFC)Help -240,758
plusdown
10,802
plusdown
31,239
plusdown
135,601
plusup
46,128
plus
Free Cash Flow(FCF)Help -207,722
plusdown
63,221
plusup
12,961
plusdown
144,476
plusup
-266,556
plus
OFC - Net IncomeHelp 60
plusdown
68
plusdown
72
plusdown
73
plusup
73
plus
Current AssetsHelp - - - - -
FCF / Current AssetsHelp -69.08%
plusdown
-10.59%
plusdown
72.04%
plusup
-3,474.28%
plusdown
-13.78%
plus
Current Assets / Amount of SalesHelp -110.79%
plusdown
-18.36%
plusdown
7.74%
plusup
-0.76%
plusup
-69.35%
plus
Free Cash Revenue RatioHelp -66.04%
plusdown
11.38%
plusup
2.31%
plusdown
28.00%
plusup
-55.22%
plus

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Sumitomo Pharma Co., Ltd.

Company where related level is highHelp

KYORIN Pharmaceutical Co., Ltd.
GNI Group Ltd.
Modalis Therapeutics Corporation
KAKEN PHARMACEUTICAL CO.,LTD.
FunPep Company Limited
CanBas Co.,Ltd.
Mochida Pharmaceutical Co.,Ltd.
Eisai Co.,Ltd.
Fuso Pharmaceutical Industries, Ltd.
StemRIM Inc.